BridgeBio Oncology Therapeutics Inc.
USD7.85
+0.19 (+2.42%)
CEO
Eli Wallace
IPO Date
2025-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.67
Prev. Close
$7.66
Day Low
$7.55
Day High
$7.85
52W Low
$7.00
52W High
$14.87
Market Cap
$0.63B
Volume
0.12M
| -2.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 101777.6% | -19435.3% | -1.10 | 0.00 | -3.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 16.1% | -2.4% | -1.97 | 0.00 | -59301.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 236.2% | -30.1% | -2.01 | 0.00 | -4814.5 |
| -2.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -10.0% | -9.2% | 0.01 | 13.33 | -1.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 12.5% | -18.8% | -0.01 | 5.22 | -2.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 11.0% | -14.7% | -0.01 | 5.87 | -3.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -10.4% | -10.1% | 0.00 | 10.40 | -2.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.3% | -9.0% | 0.00 | 16.12 | -3.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -11.8% | -11.5% | 0.00 | 26.23 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -8.5% | -8.2% | 0.00 | 90.42 | -3.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 65.6% | -12.5% | -1.10 | 0.00 | -1251.7 |